98%
921
2 minutes
20
Background: Familial focal epilepsy with variable foci 2 (FFEVF2), an autosomal dominant disorder caused by pathogenic heterozygous variants in the gene, is characterized by focal epilepsy originating in different cortical regions of the temporal, frontal, parietal, and occipital lobes of the brain.
Methods: The study included a Chinese family in which proband had epilepsy, and her brother had autism, attention deficit hyperactivity disorder (ADHD), and mild intellectual disability (ID). Blood samples of the two children and their parents were collected for whole exome sequencing (WES).
Results: Proband was a 1-month-and-7-day-old baby girl with epilepsy manifesting as focal to bilateral tonic-clonic seizures and cranial magnetic resonance imaging showing focal cortical dysplasia or subcortical grey matter ectopia in the left anterior and posterior central gyrus. WES revealed a heterozygous variant of the gene [c.907delC (p. Gln303Serfs*11)]. Sanger sequencing confirmed that the variant was inherited from her unaffected mother. According to the ACMG, the variant was classified as likely pathogenic. Finally, she was diagnosed with FFEVF2. Her epilepsy type was only reported in one patient with FFEVF2 with multiple seizure types. Follow-up revealed that she had a global developmental delay and absent language, and despite numerous antiseizure medications, her seizures were uncontrolled. Her brother carried the same mutated gene, which manifested primarily as autism, ADHD, speech deficit, and mild ID. So far, he has had no seizures and a negative electroencephalogram. But he could have seizures in the future, and it’s worth following up.
Conclusion: This study describes a family with a new variant, where affected members exhibited various neurological disorders including FFEVF2, autism, and ADHD, demonstrating incomplete penetrance.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12345022 | PMC |
http://dx.doi.org/10.1186/s12883-025-04339-6 | DOI Listing |
Neurochirurgie
September 2025
Necker Hospital, Departments of Pediatric Neurosurgery, Radiology, Pediatric Neurology and Anesthesiology; Reference Center for Rare Epilepsies CRéER, Member of ERN Epicare; APHP, Paris, France; Université de Paris Cité, Paris, France; Institut Imagine, INSERM U1163, Paris, France; Paris Kids Can
Introduction: Laser Interstitial Thermal Therapy under MRI control has emerged as a safe and efficient alternative to microsurgery in epilepsy and neurooncology procedures. Yet it has been used only recently in seldom European centers. Here, we report our 4 years' experience with LITT in children (complications, epileptic and oncologic outcomes).
View Article and Find Full Text PDFEpilepsy Res
August 2025
University of Colorado School of Medicine, Aurora, CO, USA.
Objectives: Responsive neurostimulation (RNS) electrocorticographic (ECoG) data may have a role in objectively assessing the efficacy of add-on antiseizure medications (ASMs). This retrospective, multicenter, observational, 24-week study is the first to report the effects of cenobamate on RNS-detected events (RDE).
Methods: Patients included adults (≥18 years) with a history of recurrent focal seizures and implanted RNS who initiated adjunctive cenobamate ≥ 3 months after RNS implant between 4/1/20-12/15/23 and who received ≥ 2 weeks of cenobamate (≥50 mg/day).
Pediatr Neurol
August 2025
Department of Neurology & Neurosurgery, McGill University, Montréal, Québec, Canada; Department of Pediatrics, McGill University, Montréal, Québec, Canada.
Background: Dyskinetic cerebral palsy (DCP) is a severe subtype of cerebral palsy in which children often present substantial functional impairment and multiple comorbidities. Our knowledge of the clinical picture of DCP is limited and our understanding of which markers best predict later impairment is scarce. This study aims to describe the presentation of DCP and examine the value of gestational age (GA) and magnetic resonance imaging (MRI) findings as early markers of eventual DCP prognosis.
View Article and Find Full Text PDFEpilepsia
September 2025
Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Objective: This study aims to determine whether the anatomically heterogeneous lesions that cause hyperkinetic seizures (HKS) are connected to a common functional network.
Methods: We identified patients from the Beijing Tiantan-Fengtai Epilepsy Center with HKs as the primary ictal semiology. These included patients had focal seizure-onset zone, here referred to as a "lesion.
Clin Pharmacol Drug Dev
September 2025
Shandong Xinhua Pharmaceutical Co., Ltd., Zibo, China.
Epilepsy is one of the most severe neurological disorders in the world, which might seriously endanger the lives of patients. Phenobarbital is an important medicine clinically used for the treatment of epilepsy, and it is irreplaceable in the treatment of generalized tonic-clonic seizures, focal seizures, status epilepticus, and pediatric epilepsy. However, the original research medicine of phenobarbital has not been launched in China.
View Article and Find Full Text PDF